Form 4 for HUM Humana

Accepted 2025-01-03 00:00:00 ET · period of report 2024-12-31 · accession 0001062993-25-000048 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-01-03	2025-01-02	HUM	SMITH BRAD D	Dir	A - Grant	$0.00	+783	1,169	+203%	$0
DM	2025-01-03	2024-12-31	HUM	SMITH BRAD D	Dir	A - Grant	$254.93	+248	20	New	+$63.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Humana Common	2025-01-02	A	A	783	$0.00	1,169	D	—	—	(F4) Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
2	Derivative	Restricted Stock Units	2024-12-31	A	A	231	$254.93	771	D	— · — to —	231 Humana Common	(F2) Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
3	Derivative	Restricted Stock Units	2024-12-31	A	A	17	$254.93	20	D	— · — to —	17 Humana Common	(F3) Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).